Title:
移植片拒絶の予防に使用するための抗ＣＤ４０抗体
Document Type and Number:
Japanese Patent JP6861301
Kind Code:
B2
Abstract:
The disclosure relates to methods, treatment regimens, uses, kits and therapies for preventing graft rejection in solid organ transplantation, by employing anti-CD40 antibodies.
Inventors:
SP, Pascal
Haraldson, Borje
Rush, james
Haraldson, Borje
Rush, james
Application Number:
JP2019562323A
Publication Date:
April 21, 2021
Filing Date:
April 11, 2019
Export Citation:
Assignee:
Novartis Age
International Classes:
A61K39/395; A61P37/06; C07K16/28
Domestic Patent References:
| JP2014500720A |
Other References:
Cordoba, F. et al.,"A novel, blocking, Fc-silent anti-CD40 monoclonal antibody prolongs nonhuman primate renal allograft survival in the absence of B cell depletion",Am. J. Transplant.,2015年,Vol. 15,pp. 2825-2836
Attorney, Agent or Firm:
Hiroshi Kobayashi
Eiji Katayama
Norio Omori
Wataru Ueda
Yasuhito Suzuki
Eiji Katayama
Norio Omori
Wataru Ueda
Yasuhito Suzuki